Herpes simplex virus type 2 antibody in patients attending antenatal or STD clinics
Autor: | Eva Sjögren-Jansson, Peter R. Field, Ian McCrossin, Stig Jeansson, Anthony L. Cunningham, Carmella Law, Andre J. Nahmias, David W.T. Ho, Francis K. Lee, Donald R. Packham |
---|---|
Rok vydání: | 1993 |
Předmět: |
Adult
Male Sexually transmitted disease medicine.medical_specialty Cross-sectional study Sexually Transmitted Diseases Prenatal care Antibodies Viral Ambulatory Care Facilities Asymptomatic Pregnancy Epidemiology Prevalence medicine Humans Simplexvirus Seroprevalence Pregnancy Complications Infectious Immunoassay Obstetrics business.industry Australia Herpes Simplex Prenatal Care General Medicine medicine.disease Cross-Sectional Studies Socioeconomic Factors Immunology Female Viral disease medicine.symptom business |
Zdroj: | Medical Journal of Australia. 158:525-528 |
ISSN: | 1326-5377 0025-729X |
DOI: | 10.5694/j.1326-5377.1993.tb121867.x |
Popis: | Objective To determine the prevalence of antibody to herpes simplex virus type 2 (HSV-2) in patients attending a general public antenatal clinic and three public sexually transmitted disease (STD) clinics in Sydney. Background Highly specific tests for herpes simplex type 2 antibody, using the glycoprotein G2, have been recently introduced, allowing determination of past asymptomatic infection. Overseas studies have confirmed the long held suspicion that asymptomatic infection is more common than clinical genital herpes. The seroprevalence of HSV-2 in antenatal and STD clinic patients varies markedly in different countries. These are the first data available for Australia by means of this highly specific test. Design Cross-sectional study of seroprevalence in these two patient groups. Sera used in the antenatal study were those submitted for routine antenatal screening for viral markers. Participants Two hundred and twenty-nine consecutive patients attending the Westmead Hospital antenatal clinics, and 107 consecutive patients attending three public STD clinics. Hypotheses That Australian populations show a relatively high prevalence of past asymptomatic infection with HSV-2; and that higher rates of infection will be found in patients attending STD clinics and with past or current histories of STDs. Main outcome measures Comparison of HSV-2 seroprevalence between antenatal clinic patients and STD clinic patients; and associations of HSV-2 antibody with age, sex, occupation, country of birth, a history of current or past STDs and antibody to HSV-1. Results Antibody to HSV-2 was found in 14.5% of antenatal clinic patients and 40% of STD clinic patients. None of the antenatal patients and less than half of the seropositive STD clinic patients reported clinical genital herpes. Associations with age, socioeconomic status and previous HSV-1 infection were less marked than in studies from the United States. Female STD clinic patients had a significantly higher seroprevalence than males and three times the seroprevalence of age-matched antenatal clinic patients. The correlation between HSV-2 antibody and current gonorrhoea was more marked than that between HSV-2 and other STDs. Conclusion Asymptomatic infection with HSV-2 is quite common in Australian antenatal patients and more common in patients with STDs, who have higher rates of sexual exposure. |
Databáze: | OpenAIRE |
Externí odkaz: |